Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001895505 | SCV002156159 | uncertain significance | Noonan syndrome 9 | 2022-09-19 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1381662). This missense change has been observed in individual(s) with clinical features of SOS2-related conditions (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1049 of the SOS2 protein (p.Ser1049Pro). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SOS2 protein function. |
Mayo Clinic Laboratories, |
RCV004793565 | SCV005409701 | uncertain significance | not provided | 2023-10-17 | criteria provided, single submitter | clinical testing | PM2 |